Le Lézard
Classified in: Health
Subjects: NPT, LEG, EXE, AVO

Statement on New York Times Investigation of U.S. Chamber of Commerce Global Tobacco Lobbying and Advocacy



WASHINGTON, June 30, 2015 /PRNewswire-USNewswire/ -- The following statement can be attributed to Legacy:

Legacy logo.

Great reporting opens your eyes and your mind. The New York Times [hotlink] shed light today on the role the U.S. Chamber of Commerce plays in spreading the reach of a product that, even when it is used as intended by its manufacturers, kills nearly six million people annually. The Chamber is one of the most powerful and recognizable forces in advancing the cause of industry in the United States. The Times reporting on public records obtained from the Chamber details a broad and coordinated global campaign to combat antismoking laws of all kinds in countries around the world.

Now that others in the private sector can see the systematic efforts of Big Tobacco and the U.S. Chamber to thwart sound public health measures around the world, we hope they will reconsider their involvement with and support for the U.S. Chamber of Commerce. It seems impossible that companies that have staked their reputations on advancing the health and well-being of consumers can continue to support and work with the Chamber.

We congratulate our colleagues at the Campaign for Tobacco-Free Kids for bringing attention and insight to the global efforts of Big Tobacco and the Chamber, which have their roots squarely in the U.S. and where the fight against tobacco is still not over. More than 5.6 million American youth who are alive today are expected to die prematurely of tobacco-related causes. Big Tobacco continues to be a powerful opponent to regulatory and legislative efforts around the country aimed at ending the tobacco epidemic.

Legacy

Legacy envisions an America where tobacco is a thing of the past, where all youth and young adults reject tobacco use. Legacy's proven-effective and nationally recognized public education programs include truth®, the national youth smoking prevention campaign that has been cited as contributing to significant declines in youth smoking;EX®, an innovative public health program designed to speak to smokers in their own language and change the way they approach quitting; and research initiatives exploring the causes, consequences and approaches to reducing tobacco use. Located in Washington, D.C., the foundation was created as a result of the November 1998 Master Settlement Agreement (MSA) reached between attorneys general from 46 states, five U.S. territories and the tobacco industry. To learn more about Legacy's life-saving programs, visit www.LegacyForHealth.org.

Follow us on Twitter at @legacyforhealth and on Facebook at www.Facebook.com/Legacy.

Logo - http://photos.prnewswire.com/prnh/20101101/DC86294LOGO

SOURCE Legacy


These press releases may also interest you

at 07:27
AbbVie , a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for VENCLYXTO® (venetoclax tablets) in...

at 07:27
Camurus announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use, CHMP, has adopted a positive opinion recommending approval of Buvidal® (buprenorphine) prolonged-release solution for injection for...

at 07:24
Braeburn announces that Camurus has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the marketing authorization of CAM2038, an investigational buprenorphine flexible-dose...

at 07:00
ASHEVILLE, N.C., Sept. 21, 2018 /PRNewswire-PRWeb/ -- Aeroflow Healthcare, an Inc. 5000 fastest growing company, today announced the donation and rental of medical equipment and supplies to Asheville, N.C. and Greenville, S.C. area shelters for...

at 07:00
Agenus Inc. , an immuno-oncology company with a pipeline of immune checkpoint antibodies, cancer vaccines, and adoptive cell therapies1, today announced the closing of its non-dilutive royalty transaction with XOMA Corporation (XOMA), where XOMA...

at 07:00
Global Cord Blood Corporation ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2018...




News published on 30 june 2015 at 15:55 and distributed by: